Search results
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 8 hours agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 5 hours agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 9 hours agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 8 hours agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 11 hours agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines ...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
CBS 47 Fresno· 11 hours agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop ...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WSAU Wausau· 11 hours agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 8 hours agoNovavax will also be entitled to a further $200 million in additional launch and sales milestone...
Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall By Investing.com
Investing.com· 6 hours agoNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 1 day agoIt provides an alternate treatment pathway for people who might be apprehensive of mRNA technology....